Clinical
AI ‘hindered’ by concerns over privacy, ethics
AI could help predict adverse drug reactions in hospitals, a new study says, but Alfred Health’s chief pharmacy information officer believes more evaluation is needed Artificial intelligence (AI) and machine …
‘I’ve seen lots of patients doing that’
People are “microdosing” weight loss drugs mainly due to cost or availability… a pharmacist and a GP who see this frequently share how they respond People are “microdosing” weight loss …
Supporting more contraceptive options for women
PBAC recommends new PBS listings for oral contraception plus treatment of atopic dermatitis and severe asthma in children The PBAC has recommended listing estetrol with drospirenone (Nextstellis) on the PBS …
Unlawful use of VAD substance: an ‘isolated’ incident?
Governments should consider measures that reduce harms from private self‐administration following coroner’s case, say experts Health law researchers have recommended consideration of measures to reduce harms associated with private self‐administration …
April MIMS update
Some of the recent changes to the medicines landscape, with new products, indications and contraindications New Products Momelotinib (as dihydrochloride monohydrate) (Omjjara) and its major circulating metabolite (M21) are inhibitors …
Downscheduling rejected
A leading vaginal gel will remain as a Pharmacist Only medicine, the TGA rules, while products containing deadly nightshade will be restricted to use in young children A move to …
Next gen progestogen-only pill (POP) added to PBS
Oral contraceptive with 24-hour missed pill window added to PBS, along with combination therapy for women with fertility issues Around 80,000 Australian women paying privately for the progestogen-only oral contraceptive …
Changing direction
TGA delegate overturns interim decisions on schedule changes to products containing widely used ingredients The Therapeutic Goods Administration’s (TGA) medicines scheduling committee has overturned previous interim decisions on scheduling products …
‘Use AI, but don’t rely on it for everything’
A leading pharmacist says it’s “inevitable” that AI will soon change the face of pharmacy practice, but argues that the “human touch has to remain” Associate Professor Betty Chaar is …
Playing a leading role
With pharmacist vaccinations continuing to expand, we review the space, and see how others have safely rolled out vax programs in their pharmacies It’s safe to say the pharmacist workforce …
February MIMS update
Some of the recent changes to the medicines landscape, with new products, indications and contraindications New Products RelabotulinumtoxinA (Relfydess) is a Clostridium botulinum type A neurotoxin product that blocks the …
January MIMS Update
Some of the recent changes to the medicines landscape, with new products, indications and safety-related changes New Products Amivantamab (Rybrevant) is a low-fucose, fully-human IgG1-based bispecific antibody that binds to …